FibroBiologics, Inc.
Dr. Boyer holds a Ph.D. in Molecular Sciences and Nanotechnology from Louisiana Tech University and performed his post-doctoral training on stem cells and tissue engineering at LSU-Health Sciences Center. He is currently a Senior Cell Manufacturing Scientist at FibroBiologics and focused on developing clinical manufacturing processes for cell therapies. FibroBiologics is the leading biopharmaceutical company focused on developing and commercializing fibroblast cell-based therapies for patients suffering from chronic diseases.
Disclosure information not submitted.
Scaling Production of Spheroid-Based Drug Products
Tuesday, February 6, 2024
12:00 PM – 1:00 PM EST